4 November 2019

Welcoming Bigfinite to our portfolio as they close their Series B round to Drive Disruption in Manufacturing Analytics

Welcoming Bigfinite to our portfolio as they close their Series B round to Drive Disruption in Manufacturing Analytics

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, announced that it has closed $15 million in financing with Atlantic BridgeHoneywell Ventures and Institut Català de Finances. The new funding will be used to support the market expansion of Bigfinite’s SaaS platform, an AI-powered solution that helps pharmaceutical and biotech companies discover new ways to optimize manufacturing processes, reduce quality issues, and enhance regulatory compliance.

“Atlantic Bridge has an extraordinary track record of investment into the next wave of computing including in artificial intelligence (AI), big data, and Industry 4.0 while Honeywell Ventures’ expertise in the Internet of Things, analytics, and advanced manufacturing make this an ideal investment partnership for Bigfinite,” said CEO and co-founder, Pep Gubau. “We are honored and look forward to partnering with these organizations to further scale Bigfinite’s footprint within the life science manufacturing industry.”

“It is well known that billions of dollars annually could be saved through manufacturing process improvements and that a tremendous amount of data is never used,” said Andrew Smyth, Investment Director at Atlantic Bridge. “Bigfinite’s practical use of AI to provide predictive models will save the industry millions in lost product and dramatic reduction of effort to ensure compliance and data integrity.”

“Manufacturers around the world, particularly those in highly regulated industries, are looking for new and innovative ways to use data to optimize their operations,” said Murray Grainger, managing director, Honeywell Ventures. “Honeywell is pleased to make a strategic investment in Bigfinite, whose innovative platform will allow for life sciences manufacturing to be conducted in a faster and more productive manner, while enhancing compliance.”

Existing investors including Uncork Capital, Crosslink Capital and La Famiglia all participated in this funding round, bringing the total funding to date to more than $23.5 million.

About Bigfinite, Inc.

Bigfinite is a solutions provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies. The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity. Founded in 2014, the company is based in San Francisco, California and also has a European office in Barcelona, Spain.